Literature DB >> 15923580

As-needed morphine: yes, but at what dose and at what interval?

Matthew Ryan1, Timothy J Moynihan, Charles L Loprinzi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15923580     DOI： 10.1200/JCO.2005.02.360

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

1.  Morphine inhibits doxorubicin-induced reactive oxygen species generation and nuclear factor kappaB transcriptional activation in neuroblastoma SH-SY5Y cells.

Authors:  Xin Lin; Qing Li; Yu-Jun Wang; Ya-Wen Ju; Zhi-Qiang Chi; Min-Wei Wang; Jing-Gen Liu
Journal:  Biochem J       Date:  2007-09-01       Impact factor: 3.857

2.  Morphine, a potential antagonist of cisplatin cytotoxicity, inhibits cisplatin-induced apoptosis and suppression of tumor growth in nasopharyngeal carcinoma xenografts.

Authors:  Long-Hui Cao; Hui-Ting Li; Wen-Qian Lin; Hong-Ying Tan; Lan Xie; Zhong-Jian Zhong; Jian-Hua Zhou
Journal:  Sci Rep       Date:  2016-01-05       Impact factor: 4.379
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.